ALLEGAN, Mich. (AP) -- Over-the-counter drug maker Perrigo Co. said Monday that it is now selling a generic version of Bayer HealthCare's Aleve Liquid Gels.
Perrigo said it believes is it the first company to market a generic version of Aleve Liquid Gels, which are used to treat pain. It said annual sales of the product are about $80 million.
The company also started selling a generic version of Xyzal, a treatment for allergies and hives. Xyzal is marketed in the U.S. by Sanofi-Aventis SA, which licensed the rights to the drug from UCB Pharma and Sepracor. Perrigo said U.S. sales of the tablets totaled $224 million in the 12 months ended in September. Perrigo said it will have six months of marketing exclusivity for generic Xyzal.
It launched both products after receiving approval from the Food and Drug Administration.
Perrigo stock lost 87 cents to $61.55 in morning trading.